FDA Approves Teal Wand as First At-Home Cervical Cancer Screening
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
From - Diagnostic Testing & Emerging Technologies
Since 2013 when the U.S. Food and Drug Administration (FDA) effectively stopped direct-to-consumer personal genomic testing, there has been pent up demand among healthy individuals for…
From - Diagnostic Testing & Emerging Technologies
Also at the ACMG meeting, researchers from Illumina (San Diego, Calif.) reported on a pilot project conducted at the San Diego Blood Bank where…
From - Diagnostic Testing & Emerging Technologies
Televised direct-to-consumer advertising (DTCA) is associated with greater testosterone testing, according to a study published March 21 in the Journal of the American Medical Association…
From - Diagnostic Testing & Emerging Technologies
There was an uptick in preventive screening after enactment of the Affordable Care Act (ACA), yet cancer-screening rates in the United States remain below…
From - Diagnostic Testing & Emerging Technologies
Two recent testing guidelines were released that address carrier screenings for pregnant women and a rare disease lacking a…